-
National TV show interested in exploring stigma of cancer in Asian Americans. MOASC News
-
Medi-Cal Rx program billing for brown & white bagging of drugs. California News
-
TOMORROW! February 9, 12:30pm MOASC’s LunchTime Series. MOASC News/MOASC Programs
-
TOMORROW! February 9, 7AM PST. How to avoid duplicate claims. Medicare News/Noridian News
-
THIS Saturday morning! February 12, 8:00am. Best Of San Antonio Breast Cancer Symposium Affiliate Association News/ANCO News
-
Call for abstracts due February 15 for 2022 ASCO Annual Meeting. Affiliate Association News/ASCO News
|
|
The national TV show Matter of Fact w/ Soledad O'Brien is interested in exploring the stigma of cancer in Asian Americans. MOASC member, The Oncology Institute of Hope and Innovation in LA is already being interviewed regarding the Chinese American community.
However, they are hoping to find one other Southern California practice that treats another community (e.g. Vietnamese, Korean) to add more to the story. The show is looking for an Asian American doctor who treats patients of the same ethnicity. They, and their patients, can be American-born or an immigrant but dealing not only with cancer but stigma as well. Any representative Asian nation is being solicited, ranging from Near Asia to Far Asia, as the show is seeking a variety of stories. If you are interested or have any questions, please contact:
|
|
MOASC Programs - Save the Dates - All Times are Pacific
|
|
TOMORROW! February 9, 2022, 12:30pm PST, join in MOASC’s LunchTime Series, Encore Presentation, Improving the Patient Collections Experience. PayGround’s Patient-First platform enables patients (and their dependents) to manage ALL bills in one place from across ALL their providers, helping them understand their responsibility while providing multiple payment methods to fulfill that responsibility. This leads to an average 23% patient collections improvement and 6.7 days average reduction in A/R days.
PayGround has already been adopted by multiple MOASC members and the average yearly savings is estimated to be just over $10,000 in the first year.
|
|
February 23, 2022, MOASC presents their Lung Cancer Series webinar on the Treatment of KRAS Mutated Non-Small Cell Lung Cancer. Join Hatim Husain, MD, University of California San Diego, Jonathan Riess, M.D., University of California, Davis, and Sukhmani Padda, M.D., Cedars-Sinai Medical Center for a lively discussion. This is also a great opportunity to learn from key opinion leaders and network with colleagues. Submit your questions and cases, in advance, for discussion with key opinion leaders in the field. Hear the latest clinical trial data, apply it to your patients, consider real-world scenarios and how to mitigate barriers to treatment.
|
|
March 26, 2022 - MOASC’s 7th Annual Oncology Summit & Research Symposium at the Hyatt Regency in Huntington Beach. This LIVE Meeting will follow a multi-tumor approach with nationally recognized speakers, which will review personalized cancer care and current clinical trials in Breast, Gastrointestinal, Genitourinary, Lung, CAR-T/Transplant and Myeloma. This will be a great opportunity to learn from experts and network with colleagues.
|
|
Career News
Sign up now to receive the MOASC Job Flash™! Please activate your new job alert.
|
|
MOASC Clinical Trial Database is on the MOASC website at www.moasc.org
|
|
MOASC has been in receipt of many member questions regarding the brown/white bagging coverage under new Medi-Cal Rx program. The following comes from the Medi-Cal Rx Education Outreach at Magellan Health to MOASC.
If a pharmacy furnishes medication to the beneficiary and the beneficiary takes it to the physician’s office for it to be administered, then it would be processed by Medi-Cal Rx. If the pharmacy bills Medi-Cal Rx and then they deliver the medication directly to the physician’s office (on behalf of the beneficiary) to be administered then it would be processed through Medi-Rx. When the pharmacy acts as a supplier to the physician’s office then this would not be processed by Medi-Cal Rx. For more information about Physician Administered Drugs, please refer to section 15.8 in the provider manual and the PAD CDL.
If your practice is experiencing problems billing for physician administered drugs under the Medi-Cal managed care program, please contact the California Medical Association at (800) 786-4262 or economicservices@cmadocs.org or the MOASC Office moasc@moasc.org
|
|
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R5 - Effective January 01, 2022. This Billing and Coding Article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212.
|
|
Billing and Coding: MolDX: MammaPrint (A54445) - R7 - Effective January 01, 2022. This Billing and Coding Article has been revised and published for notice under contract numbers: 01112 (NCA), 01182.
|
|
Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx® (A55295) - R7 - Effective January 06, 2022. This Billing and Coding Article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
|
|
How to avoid duplicate claims, February 9, 2022, 7:00AM PST. Duplicate denials continue to be one of the top billing errors. Unnecessary duplicate filing of Medicare claims cost the provider's office valuable time and resources as well as Medicare's time and money to process them.
|
|
Reducing Unprocessable Claim Rejections - February 10, 2022
When claims are submitted with invalid, incomplete or incorrect information, the claims processing system will detect these errors and will reject claims as unprocessable. The goal is to assist providers in submitting claims correctly the first time. Join this webinar to review the common errors found and what appropriate next steps should be taken.
|
|
Steps to Claim Corrections – February 15, 2022
This webinar includes the top continuous errors found with claim submissions. Join this webinar to learn how to correct your claims. This webinar will also include an interactive segment on the different claim scenarios that cause claim and payment delays and offer steps to correct them.
|
|
Evaluation and Management Updates Webinar - February 17, 2022
This event includes: Evaluation and Management Codes 99202-99215, AMA Errata and Technical Corrections, and Resources.
|
|
The Open Payments data has been updated to reflect changes to the data that took place since the last publication in June 2021. The updated dataset is now available for viewing.
|
|
CMS Developing Initiative to Enable Access to Eight Free Over-the-Counter COVID-19 Tests for Medicare Beneficiaries in Early Spring
As part of the Biden-Harris Administration’s ongoing efforts to expand Americans’ access to free testing, people in either Original Medicare or Medicare Advantage will be able to get over-the-counter COVID-19 tests at no cost starting in early spring. This is the first time that Medicare has covered an over-the-counter test at no cost to beneficiaries.
|
|
COVID-19: Letter to Health Care Facility Administrators on Health Care Worker Vaccination Rule |
|
In furthering his #CancerMoonshot, @POTUS reiterated the importance of screenings and prevention, “screening is how you catch it early, before it’s too late.” We are proud to support the president and @RepRaulRuiz whose work on the Medicare Multi-Cancer Early Detection Screening Coverage Act will help ensure seniors can access vital, life-saving technologies and deliver on our shared goal of ending cancer as we know it.
|
|
60% of caregivers stated that they did not predict how intense the responsibility would be, expressing that a care management tool would have been beneficial while delivering care to their relatives. Cancer patients and caregivers prioritize different concerns during treatments, providers should address both in order to enhance the patient’s experience.
|
|
Affiliate Association News |
|
Applications for ANCO’s Travel Awards to Fellows and Young Clinicians are due March 31. This award is to support attendance at the ASCO Annual Meeting, ASH Annual Meeting, or other national oncology meeting in 2022 are now being accepted. Awards will be announced by April 30.
|
|
THIS Saturday morning, February 12, 2022, ANCO, with the organizing committee of the San Antonio Breast Cancer Symposium and Encore Medical Education, will host the Best of San Antonio Breast Cancer Symposium Northern California (Best of SABCS West Coast) at The InterContinental San Francisco. Hope S. Rugo, M.D., UC San Francisco, is the Regional Director for Best of SABCS West Coast. Live Streaming option is available.
|
|
March 11-13, 2022, the 22nd Multidisciplinary Management of Cancers: A Case-based Approach returns to the Silverado Resort and Spa in Napa. The meeting is sponsored by the Association of Northern California Oncologists, Stanford Cancer Institute, UC Davis Comprehensive Cancer Center, and the UCSF Helen Diller Family Comprehensive Cancer Center. Registration is now open for HCP for in person and virtual attendance.
|
|
There is a call for abstracts due by February 15, 2022 for the 2022 ASCO Annual Meeting.
|
|
The 2022 ASCO Annual Meeting is being held live in Chicago on June 3-7, 2022. Early conference registration deadline is April 17, 2022 at 8:59pm PDT.
|
|
February 28! Mark your calendar to attend the latest webinar in the ASH Precision Hematology Series. This series is designed to provide clinicians and researchers in hematology foundational information on the latest technologies available for data acquisition, diagnosis, and decision-making for hematologic diseases. All webinars from this series are available on ASH Academy On Demand.
|
|
COA issued a statement on the Cancer Moonshot relaunch, which was introduced by President Biden last week Feb. 2.
|
|
Have you registered for the 2022 COA Conference, yet? Save your seat. Reserve your room for a discount through February 20th. On March 17-18, oncology professionals from around the country will gather at the Gaylord Palms Hotel in Kissimmee, Florida for the best oncology conference in the country.
|
|
NCCN has published updates to NCCN Guidelines® and are currently available as Version 1.2022.
-
In the NCCN Clinical Practice Guidelines in Oncology; the NCCN Drugs and Biologics Compendium (NCCN Compendium®) is: Gastrointestinal Stromal Tumors (GISTs).
-
In the NCCN Radiation Therapy Compendium™, the NCCN Radiation Therapy Compendium™, NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™), and the NCCN Compendium® is: Primary Cutaneous Lymphomas.
-
In the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) with NCCN Evidence Blocks™ is: Neuroendocrine and Adrenal Tumors, Version 4.2021;
-
Esophageal and Esophagogastric Junction Cancers;
- Squamous Cell Skin Cancer
|
|
The Medical Oncology Association of Southern California (MOASC) is a leading oncology society that advances and protects the ability of cancer patients to obtain, and the ability of the oncology physicians to provide, optimal cancer care. The material contained in the California Oncology Weekly is intended as general information for MOASC members. Because diagnostic, treatment, contracting, coding, and billing decisions should be made on a case-by-case basis, any such information contained in the California Oncology Weekly may not apply in any given situation. Members are encouraged to contact their own consultants or advisors to obtain specific advice on matters relating to contracting, coding, and billing. The information contained in California Oncology Weekly should not be used as a substitute for such advice. This publication provides a summary of regulations affecting oncology and its business practices. Reading this newsletter does not substitute for understanding regulations and verifying the validity of every claim. This information is time-sensitive and is subject to change. MOASC accepts no liability for any statements or articles herein. CPT codes are owned and trademarked by the American Medical Association. All Rights Reserved.
|
|
|
|
|
|
|
